SR125047

ID: Reference2787

C₂₂H₂₆ClNO

1-[(2Z)-3-(2-Chloro-3'-methoxy-4-biphenylyl)-2-propen-1-yl]azepane; 1H-Azepine, 1-[(2Z)-3-(2-chloro-3'-methoxy[1,1'-biphenyl]-4-yl)-2-propen-1-yl]hexahydro-

SB236057A

ID: Reference2878

C₃₃H₃₄N₄O₃

(1'-Ethyl-6,7-dihydro-5H-spiro[furo[2,3-f]indole-3,4'-piperidin]-5-yl)[2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylyl]methanone; SB236057; Methanone, (1'-ethyl-6,7-dihydrospiro[2H-furo[2,3-f]indole-3(5H),4'-piperidin]-5-yl)[2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)[1,1'-biphenyl]-4-yl]-

CP-105696

ID: Reference2995

C₂₈H₂₈O₄

1-[(3S,4R)-3-(4-Biphenylylmethyl)-4-hydroxy-3,4-dihydro-2H-chromen-7-yl]cyclopentanecarboxylic acid; CP 105696; 1-[(3S,4R)-3-Biphenyl-4-ylmethyl-4-hydroxy-chroman-7-yl]-cyclopentanecarboxylic acid ; 1-[(3S,4R)-4-Hydroxy-3-[(4-phenylphenyl)methyl]chroman-7-yl]cyclopentane-1-carboxylic acid; Cyclopentanecarboxylic acid, 1-[(3S,4R)-3-([1,1'-biphenyl]-4-ylmethyl)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-7-yl]-

Difenacoum

ID: Reference3007

C₃₁H₂₄O₃

3-[3-(4-Biphenylyl)-1,2,3,4-tetrahydro-1-naphthalenyl]-4-hydroxy-2H-chromen-2-one; Difenakum; Diphenacoum; Neosorex; Neosorexa; Ratak; 3-[3-(4-Biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl]-4-hydroxycoumarin

2-Tolidine

ID: Reference3119

C₁₄H₁₆N₂

3,3'-Dimethyl-4,4'-biphenyldiamine; o,o'-Tolidine ; o-Tolidin; o-Tolidine; 2-Tolidin; 3,3'-Tolidine; 4,4'-Bi-o-Toluidine

FR130739

ID: Reference3194

C₂₄H₂₃N₇

2-Butyl-3-{[2'-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-3H-imidazo[4,5-b]pyridine; FK-739

3,3',5,5'-Tetramethylbenzidine

ID: Reference3211

C₁₆H₂₀N₂

3,3',5,5'-Tetramethyl-4,4'-biphenyldiamine; (1,1'-Biphenyl)-4,4'-diamine, 3,3',5,5'-tetramethyl-; (1,1'-Biphenyl)-4,4-diamine, 3,3',5,5'-tetramethyl-; 3,3',5,5'-Tetramethyl benzidine; 3,3',5,5'-Tetramethyl(1,1'-biphenyl)-4,4'-diamine; 3,3',5,5-Tetramethylbenzidine; 3,3,5',5'-Tetramethylbenzidine

Losartan

ID: Reference3320

C₂₂H₂₃ClN₆O

(2-Butyl-4-chloro-1-{[2'-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazol-5-yl)methanol; Lortaan; (1-{[2'-(1H-Tetrazol-5-yl)-(1,1'-biphenyl)-4-yl]methyl}-2-butyl-4-chloro-1H-imidazol-5-yl)methanol ; (2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol; (2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol; (2-Butyl-4-chloro-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol; [2-Butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol

Valsartan metabolite

ID: Reference3547

C₁₄H₁₀N₄O₂

2'-(1H-Tetrazol-5-yl)-4-biphenylcarboxylic acid; 2'-(2H-Tetrazole-5-yl)-1,1'-biphenyl-4-carboxylic acid

Candesartan cilexetil

ID: Reference4995

C₃₃H₃₄N₆O₆

1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate; Candesartan cilexitil; Kenzen; Parapres; Racanda; Tcy 116; 1-(Cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-1H-benzimidazole-7-carboxylate

URB597

ID: Reference5002

C₂₀H₂₂N₂O₃

3'-Carbamoyl-3-biphenylyl cyclohexylcarbamate; BR-40097; FAAH Inhibitor II; KDS-4103; [3'-(Aminocarbonyl)(1,1'-biphenyl)-3-yl]-cyclohexylcarbamate ; [3-(3-Carbamoylphenyl)phenyl] N-cyclohexylcarbamate; N-Cyclohexylcarbamic acid [3-(3-carbamoylphenyl)phenyl] ester

LY2183240

ID: Reference5514

C₁₇H₁₇N₅O

5-(4-Biphenylylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide; LY-2183240; N,N-Dimethyl-5-[(4-phenylphenyl)methyl]-1,2,3,4-tetrazole-1-carboxamide; N,N-Dimethyl-5-[(4-phenylphenyl)methyl]-1H-1,2,3,4-tetrazole-1-carboxamide; 1H-Tetrazole-1-carboxamide, 5-([1,1'-biphenyl]-4-ylmethyl)-N,N-dimethyl-; 5-([1,1'-Biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide; 5-Biphenyl-4-ylmethyl-tetrazole-1-carboxylic acid dimethylamide